美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72162-2570-3	72162-2570	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20251117	N/A	ANDA	ANDA205209	Bryant Ranch Prepack	DARIFENACIN HYDROBROMIDE	7.5 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2570-3)
13668-202-05	13668-202	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118	N/A	ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-05)
13668-202-30	13668-202	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118	N/A	ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-30)
13668-202-90	13668-202	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118	N/A	ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-90)
13668-203-05	13668-203	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118	N/A	ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-203-05)
13668-203-30	13668-203	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118	N/A	ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-203-30)
13668-203-90	13668-203	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118	N/A	ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-203-90)
72162-2571-3	72162-2571	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20251117	N/A	ANDA	ANDA205209	Bryant Ranch Prepack	DARIFENACIN HYDROBROMIDE	15 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2571-3)